Project Details
Description
Larotrectinib for Previously Untreated NTRK-fusion Positive Pediatric Solid Tumors and NTRK-fusion Positive Relapsed Pediatric Acute Leukemias
| Status | Active |
|---|---|
| Effective start/end date | 4/1/22 → 4/26/25 |
Funding
- PUBLIC HEALTH INSTITUTE
- BAYER AG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.